Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary shares, par value $0.000174
- Shares outstanding
- 62,516,710
- Total 13F shares
- 2,944,726
- Share change
- +70,543
- Total reported value
- $4,229,340
- Price per share
- $1.44
- Number of holders
- 11
- Value change
- +$101,251
- Number of buys
- 4
- Number of sells
- 3
Report period
Q3 2024
Institutions
11
Top holders
10
CNTB full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
|
Company |
3.3%
|
2,043,248
|
$3,105,737 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.82%
|
510,701
|
$776,266 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.34%
|
212,300
|
$322,696 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.17%
|
103,891
|
$157,914 | — | 30 Jun 2024 | |
| Keudell/Morrison Wealth Management |
13F
|
Company |
0.05%
|
32,200
|
$48,944 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,961
|
$42,500 | — | 30 Jun 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
20,000
|
$30,000 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
12,700
|
$19,000 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
9,500
|
$14,439 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,568
|
$5,423 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$184 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
46
|
$70 | — | 30 Jun 2024 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) as of Q3 2024
As of 30 Sep 2024,
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,944,726 shares.
The largest 10 holders included
BML Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), RENAISSANCE TECHNOLOGIES LLC, Callan Capital, LLC, Keudell/Morrison Wealth Management, Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, RHUMBLINE ADVISERS, and BlackRock, Inc..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
12
Q3 2024 holders
11
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.